A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors (Q42990860)
Jump to navigation
Jump to search
scientific article published on 10 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors |
scientific article published on 10 September 2009 |
Statements
1 reference
A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors (English)
1 reference
Robert Chase
1 reference
Angela Skelton
1 reference
Ellen Xia
1 reference
Stephanie Curry
1 reference
Shaotang Liu
1 reference
Patricia McMonagle
1 reference
H-C Huang
1 reference
Xiao Tong
1 reference
10 September 2009
1 reference
1 reference
84
1 reference
2
1 reference
178-184
1 reference
Identifiers
1 reference
1 reference